“…Biochemically, ferroptosis can be suppressed by various small molecules, involving iron chelators (e.g., deferoxamine), lipophilic antioxidants (e.g., α -tocopherol), and lipid peroxidation inhibitors [ 21 – 24 ] that to the maximum extent do not similar with other forms of RCD [ 1 , 5 , 25 , 26 ]. Moreover, while numerous genes including p53 [ 7 , 27 , 28 ], nuclear factor E2-related factor 2 ( Nrf2 ) [ 29 , 30 ], and autophagy-related ( ATG ) genes [ 9 , 31 ] modulate different RCDs, a distinct set of genes such as ribosomal protein L8 ( RPL8 ), ATP synthase F0 complex subunit C3 ( ATP5G3 ), tetratricopeptide repeat domain 35 ( TTC35 ), citrate synthase, and iron response element binding protein 2 ( IREB2 ) seems peculiar to regulate ferroptosis [ 1 ]. As ferroptosis shares different mechanisms with other forms of cell death, it could unquestionably circumvent their limitations.…”